药物警戒比例失衡分析中的因果陈述在引用中是否被夸大?一项元流行病学研究
该元流行病学研究探讨了药物警戒比例失衡分析中标题和摘要结论的因果陈述强度与引用文献因果语言强度的关系。研究选取30篇Altmetric关注度最高的比例失衡研究及其622篇引用文献,发现45.8%的引用文献使用无条件因果陈述,且引用文献的因果强度与源文献摘要结论的因果强度正相关(p<0.00001)。
要点
- 近半数引用比例失衡分析的研究使用无条件因果表述,仅26.4%用词恰当。
- 源文献摘要结论的因果强度越强,引用文献的因果陈述也越强。
- 撰写、解读和引用比例失衡研究时需更加谨慎。
核心结论
- 近半数引用药物警戒比例失衡分析结果的研究使用了因果断言,尤其当源文献使用更强因果语言时。
- 撰写、解读和引用比例失衡研究时需要更加谨慎。
研究设计与样本
- 元流行病学研究,于2022年3月30日选取Altmetric关注度最高的30篇比例失衡研究,并提取其所有引用研究(n=1434)。
- 由两名作者采用四级量表(1-恰当解读;2-模糊解读;3-有条件因果;4-无条件因果)评估源文献和引用文献的因果语言强度。
- 通过多项式回归模型评估源文献与引用文献因果陈述强度的关联。
主要发现
- 27%(n=8)的源研究在标题中使用无条件因果陈述,30%(n=9)在摘要结论中使用,17%(n=5)在两者中均使用。
- 仅20%(n=6)的源研究在标题和摘要结论中均使用恰当陈述。
- 在分析的622篇引用研究中,285篇(45.8%)在引用比例失衡分析结果时使用无条件因果陈述,仅164篇(26.4%)使用恰当语言。
- 引用研究的因果陈述强度与源文献摘要结论的因果语言强度正相关(似然比检验 p<0.00001),但与标题无关。
- 在引用源文献解读恰当的研究中,30.2%(95%CI 22.8-37.6)的摘要结论包含无条件因果陈述;而引用源文献使用无条件因果陈述的研究中,该比例为56.4%(95%CI 48.7-64.2)。
临床怎么用
- 临床药学人员在引用比例失衡分析结果时,应避免直接使用因果断言,需结合其他证据谨慎解读。
- 关注源文献摘要结论的因果语言强度,警惕其对引用行为的潜在影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous meta-epidemiological surveys have found considerable misinterpretation of results of disproportionality analyses. We aim to explore the relationship between the strength of causal statements used in title and abstract conclusions of pharmacovigilance disproportionality analyses and the strength of causal language used in citing studies. METHODS: On March 30, 2022, we selected the 30 disproportionality studies with the highest Altmetric Attention Scores. For each article, we extracted all citing studies using the Dimension database (n = 1434). In parallel, two authors assessed the strength of causal statements in the title and abstract conclusions of source articles and in the paragraph of citing studies. Based on previous studies, the strength of causal language was quantified based on a four-level scale (1-appropriate interpretation; 2-ambiguous interpretation; 3-conditionally causal; 4-unconditionally causal). Discrepancies were solved by discussion until consensus among the team. We assessed the association between the strength of causal statements in source articles and citing studies, separately for the title and abstract conclusions, through multinomial regression models. RESULTS: Overall, 27% (n = 8) of source studies used unconditionally causal statements in their title, 30% (n = 9) in their abstract conclusion, and 17% (n = 5) in both. Only 20% (n = 6) used appropriate statements in their title and in their abstract's conclusions. Among the 622 citing studies analyzed, 285 (45.8%) used unconditionally causal statements when referring to the findings from disproportionality analysis, and only 164 (26.4%) used appropriate language. Multinomial models found that the strength of causal statements in citing studies was positively associated with the strength of causal language used in abstract conclusions of source articles (Likelihood Ratio Test (LogLRT) p < 0.00001) but not in the titles. In particular, among studies citing source articles with appropriate interpretation, 30.2% (95% confidence interval [CI] 22.8-37.6) contained unconditionally causal statements in their abstract conclusions, versus 56.4% (95% CI 48.7-64.2) for studies citing source articles with unconditionally causal statements. CONCLUSIONS: Nearly half of the studies citing pharmacovigilance disproportionality analyses results used causal claims, particularly when the causal language used in the source article was stronger. There is a need for higher caution when writing, interpreting, and citing disproportionality studies.
引用
- Bernardeau C, Revol B, Salvo F, et al. Are Causal Statements Reported in Pharmacovigilance Disproportionality Analyses Using Individual Case Safety Reports Exaggerated in Related Citations? A Meta-epidemiological Study. Drug Saf. 2025. PMID: 39987376. doi:10.1007/s40264-025-01524-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。